Literature DB >> 21397435

The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.

C Gilor1, T K Graves, S Gilor, T K Ridge, H-Y Weng, O Dossin.   

Abstract

Incretin hormones are secreted from the intestines in response to specific nutrients. They potentiate insulin secretion and have other beneficial effects in glucose homeostasis. We aimed to study the incretin effect in cats and to compare the effect of oral glucose, lipids, or amino acids on serum concentrations of insulin, total glucose-dependent insulinotropic peptide (GIP) and total glucagon-like peptide 1 (GLP-1). Ten healthy cats were used in a repeated measures design. Glucose, lipid, or amino acids were administered through nasoesophageal tubes on separate days. Blood glucose (BG) concentrations were matched between experiments by measuring BG every 5 min and infusing glucose intravenously at a changing rate. Intravenous glucose infusion with no prior treatment served as control. The incretin effect was estimated as the difference in insulin area under the curve (AUC) after oral compared with intravenous glucose. Temporal changes and total amount of hormone secretions were compared between treatment groups with the use of mixed models. Total glucose infused (TGI) at a mean dose of 0.49 g/kg resulted in slightly higher BG compared with 1 g/kg oral glucose (P = 0.038), but insulin concentrations were not significantly different (P = 0.367). BG and the TGI were not significantly different after the 3 oral challenges. Total GIP AUC was larger after lipids compared with amino acids (P = 0.0012) but GIP concentrations did not increase after oral glucose. Insulin and GIP concentrations were positively correlated after lipid (P < 0.001) and amino acids (P < 0.001) stimulations, respectively, but not after oral glucose stimulation. Total GLP-1 AUC was similar after all three oral stimulations. Insulin and GLP-1 concentrations were positively correlated after glucose (P = 0.001), amino acids (P < 0.001), or lipids (P = 0.001) stimulations. Our data indirectly support an insulinotropic effect of GIP and GLP-1. Potentiation of insulin secretion after oral glucose is minimal in cats and is mediated by GLP-1 but not GIP.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397435     DOI: 10.1016/j.domaniend.2011.01.002

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  7 in total

1.  Changes in glucose tolerance and insulin secretion in a cohort of cats with chronic obesity.

Authors:  Ruchita P Ahuja; Jon M Fletcher; L Abbigail Granger; Chin-Chi Liu; Bruna Miessler; Mark A Mitchell
Journal:  Can J Vet Res       Date:  2022-07       Impact factor: 0.897

2.  Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation.

Authors:  Melody Anne de Laat; Murad Hasan Kheder; Christopher Charles Pollitt; Martin Nicholas Sillence
Journal:  PLoS One       Date:  2018-06-29       Impact factor: 3.240

3.  Cacao liquor procyanidins prevent postprandial hyperglycaemia by increasing glucagon-like peptide-1 activity and AMP-activated protein kinase in mice.

Authors:  Yoko Yamashita; Masaaki Okabe; Midori Natsume; Hitoshi Ashida
Journal:  J Nutr Sci       Date:  2019-01-16

4.  The daytime feeding frequency affects appetite-regulating hormones, amino acids, physical activity, and respiratory quotient, but not energy expenditure, in adult cats fed regimens for 21 days.

Authors:  Alexandra Camara; Adronie Verbrugghe; Cara Cargo-Froom; Kylie Hogan; Trevor J DeVries; Andrea Sanchez; Lindsay E Robinson; Anna K Shoveller
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

5.  Physiological and pharmacological actions of glucagon like peptide-1 (GLP-1) in domestic animals.

Authors:  Jorge F A Model; Débora S Rocha; Alessa da C Fagundes; Anapaula S Vinagre
Journal:  Vet Anim Sci       Date:  2022-03-23

6.  Effect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus.

Authors:  A Riederer; E Zini; E Salesov; F Fracassi; I Padrutt; K Macha; T M Stöckle; T A Lutz; C E Reusch
Journal:  J Vet Intern Med       Date:  2015-12-24       Impact factor: 3.333

Review 7.  What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.

Authors:  C Gilor; S J M Niessen; E Furrow; S P DiBartola
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.